Total Funding
54
55
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
110843
Thabor Therapeutics develops innovative treatments for mucosal inflammatory diseases.
- Stéphanie Beq: R&D DirectorPast Role: HiFiBiO Therapeutics, Head of Translational Science and Senior Director
- Jeremie Mariau: CEOPast Role: Iltoo Pharma, CEO
About the Company
Thabor Therapeutics develops innovative treatments for mucosal inflammatory diseases. They concentrated on inhibiting a new target to treat human mucosal inflammatory disorders. They also enable healthcare providers to cure their patients.
